Recordati Will Adopt Orphan Europe For $191 Million
Italian firm, which has mainly focused on primary care, anticipates deal will help establish its presence in the growing European specialty pharma market.
Italian firm, which has mainly focused on primary care, anticipates deal will help establish its presence in the growing European specialty pharma market.